Drug Companies Sue HHS to Block Price Rule

They’re mad as heck and they ain’t gonna take it anymore, so we’ll see you in court, says Big Pharma.

hhs-resets-hipaa-finesMerck, Eli Lilly and Amgen are being joined by the National Association of Advertisers in suing the Department of Health and Human Services (HHS) over a rule taking effect in July that will force manufacturers to reveal pricing in their consumer drug ads.

Their bone of contention: The rule violates their freedom of speech and will deter patients from using the drugs because list prices are generally higher than market prices, which are subject to negotiation and are often lower, according to the lawsuit.

“If the drug companies are embarrassed by their prices or afraid that the prices will scare patients away, they should lower them,” HHS spokesperson Caitlin Oakley said. “President Trump and Secretary Azar are committed to providing patients the information they need to make their own informed health care decisions.”

NOTE: The details in this blog are provided for informational purposes only. All answers are general in nature and do not constitute legal advice. If legal advice or other expert assistance is required, the services of a competent professional should be sought. The author specifically disclaims any and all liability arising directly or indirectly from the reliance on or use of this blog.
You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply

Your email address will not be published. Required fields are marked *

* Copy This Password *

* Type Or Paste Password Here *

Leave a Reply

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Comments (required)*